What the company does
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma …
What the weekly tape is saying
ABBV closed the latest completed week at 193.8 EUR. The 4-week return is 7.1% and the 12-week return is 9.4%. Trend Signal is inactive, Market Dynamics is 0.32. Setup signature: Balanced read with a 59/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 186.5 EUR
- Vs Trend Line
- 3.9%
- Fair Value
- 158.9 EUR
- Vs Fair Value
- 21.9%
- 52W High
- 201.9 EUR
- 52W Low
- 149.9 EUR
- Drawdown
- -4.0%
- Range Position
- 84.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 25
- 52W Active Breadth
- 48.1%
- Sector Scope
- AT Healthcare
- Sector Rank
- 77 of 112
- Sector Percentile
- 31.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 31 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Drug Manufacturers - General
- Tracked Peers
- 17
- 4W Rank
- 4 of 17
- Avg 1W
- -0.8%
- Avg 4W
- 2.5%
- Trend Breadth
- 58.8%
- Positive RS
- 17.6%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.32
- 4W MD Change
- 135.1%
- Relative Strength
- -12.74
- 4W RS Change
- 8.2%
- Expectation
- Undecided
- Probability
- 53.87%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 91
- 13W Average
- 27
- 52W Average
- 19
- Vs 13W
- 3.3x
- Vs 52W
- 4.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.9%
- 52W Volatility
- 3.3%
- Upside Weeks
- 26
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 2.9% / -2.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
- Market Cap
- 330.0B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Recent volatility is running well above the one-year baseline.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 193.8 EUR | -2.4% | 186.5 EUR | 158.9 EUR | 0.32 | -12.74 | 91 | Off |
| 5 Jun 2026 | 198.6 EUR | 6.9% | 186.6 EUR | 158.4 EUR | -0.13 | -8.31 | 0 | Off |
| 29 May 2026 | 185.8 EUR | -0.9% | 186.1 EUR | 157.8 EUR | -0.62 | -15.27 | 0 | Off |
| 22 May 2026 | 187.4 EUR | 3.6% | 186.1 EUR | 157.4 EUR | -0.71 | -12.39 | 0 | Off |
| 15 May 2026 | 180.9 EUR | 5.9% | 186.3 EUR | 156.9 EUR | -0.91 | -13.87 | 2 | Off |
| 8 May 2026 | 170.8 EUR | -5.9% | 186.7 EUR | 156.5 EUR | -0.86 | -19.23 | 0 | Off |
| 1 May 2026 | 181.5 EUR | 7.6% | 187.6 EUR | 156.2 EUR | -0.84 | -13.21 | 64 | Off |
| 24 Apr 2026 | 168.6 EUR | -5.5% | 188.1 EUR | 155.8 EUR | -0.99 | -19.18 | 0 | Off |
| 17 Apr 2026 | 178.5 EUR | 0.6% | 188.6 EUR | 155.5 EUR | -0.95 | -17.78 | 181 | Off |
| 10 Apr 2026 | 177.4 EUR | -2.0% | 188.8 EUR | 155.2 EUR | -1.10 | -16.59 | 16 | Off |
| 3 Apr 2026 | 181.0 EUR | -0.3% | 188.9 EUR | 154.9 EUR | -0.83 | -9.74 | 0 | Off |
| 27 Mar 2026 | 181.6 EUR | 2.6% | 188.7 EUR | 154.5 EUR | -0.53 | -6.81 | 0 | Off |
| 20 Mar 2026 | 177.0 EUR | -8.9% | 188.5 EUR | 154.2 EUR | -0.25 | -8.21 | 0 | Off |
| 13 Mar 2026 | 194.3 EUR | -0.4% | 188.3 EUR | 153.9 EUR | -0.15 | -1.07 | 3 | On |